New synthetic molecules trigger immune response to HIV and prostate cancer

Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.

Read the whole article on Biology News Net

More from Biology News Net